Research Summary • Human Trial Evidence

NAD+: What the Clinical Trials Actually Show

📄 2 PubMed citations

Last updated: March 2026

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme essential to cellular energy metabolism, DNA repair, and sirtuin signaling. The review this guide draws on describes NAD+ levels falling with age, attributing it to reduced biosynthesis, increased consumption (by enzymes such as PARPs and CD38), or both. Human trials show NMN and NR raise NAD+ levels, with short-term tolerability reported.

🧪 Buy NAD+ at Swiss Chems →
Code HIGHPEP10: 10% off regular-priced items
1906
First Described
4
Precursor Pathways Studied

Build your own printable peptide tracker

A personalized injection log, weekly dosing schedule and dated calendar: your compounds filled in, ready to print. Free to build and preview; $5/month to unlock printing.

Stacking compounds? Check interactions first →

Build your tracker →

What Is NAD+?

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every living cell. First described in 1906 by Arthur Harden and William John Young, in yeast extract. A 2025 review describes it as a central metabolic cofactor and signaling molecule involved in energy metabolism, mitochondrial function, inflammation, and DNA repair.

⚡

Energy Metabolism

Central to converting food into cellular energy (ATP). Required by mitochondria for the electron transport chain.

🧬

DNA Repair

A critical co-substrate for DNA-repair enzymes, particularly PARPs, which are major consumers of NAD+ (Khatri et al. 2025).

🔄

Cellular Signaling

Sirtuins are NAD+-dependent enzymes; the 2025 review describes sirtuins and PARPs as central to maintaining genomic integrity and chromatin structure.

🧹

Cellular Cleanup

Helps regulate autophagy, your cells' garbage collection system that removes damaged components and recycles them.

Why NAD+ Declines With Age

The 2025 review attributes the age-related fall in NAD+ to reduced biosynthesis, increased consumption, or both. This page cites no dataset for how large that decline is at any given age.

"

Aging is associated with a gradual decline of intracellular NAD+ levels due to reduced NAD+ biosynthesis, increased NAD+ consumption or both.

— Khatri, Abdellatif & Sedej, Geromedicine 2025 (Figure 2 legend)

The Four Precursor Pathways

The 2025 review calls precursor supplementation the most practical and extensively studied way to raise NAD+, while noting it remains unclear how different precursors are absorbed, converted, and delivered to tissues in humans. Four main compounds have been studied in humans, each entering the biosynthesis pathway at a different step.

NR: Two Steps Out

NR (Nicotinamide Riboside)

Patented as Niagen/Tru Niagen. Two steps from NAD+.

Status Available as supplement. NR chloride was the subject of FDA GRAS notice GRN 635 (2016) for specified food uses; FDA had no questions.
Findings Raises blood NAD+ in human trials.
Koniver "Can reduce inflammation but data is sparse; less costly than NAD and NMN but doesn't seem as effective."
Niacin: The OG

Niacin / Nicotinic Acid (NA)

The cheapest NAD+ precursor. Vitamin B3 you've had your whole life.

Status FDA-approved for dyslipidemia. Decades of clinical use.
Benefits Raises HDL cholesterol, lowers triglycerides. No cardiovascular-outcome benefit is cited on this page.
⚠️ Watch Flushing (skin redness/warmth) at higher doses.
NAM: The Paradox

NAM (Nicotinamide)

Most common dietary form. Found in fortified foods everywhere.

Reality In lab studies, nicotinamide inhibits the sirtuins yeast Sir2 and human SIRT1 in vitro (PMID: 12297502) — NAD+-dependent enzymes. Whether this matters at supplement doses in humans is not established.
Verdict Like NR and NMN, it does not cause niacin's flushing, and the 2025 review says it has a more established safety profile than NR or NMN, supported by phase 3 trials; the review also notes NAM trials in early Alzheimer's disease showed limited efficacy.

What the Clinical Trials Actually Found

From the 2025 review by Khatri, Abdellatif & Sedej (Geromedicine). Here's what the human trial evidence it summarizes supports.

Consistently Demonstrated

  • Oral NR and NMN were generally well tolerated in completed trials
  • Oral NR and NMN do raise blood NAD+ levels measurably
  • No serious adverse effects in completed oral NR/NMN trials

Mixed or Limited

  • Physical performance improvements: modest and inconsistent
  • Muscle mass/strength effects: non-significant in meta-analysis
  • Cognitive benefits: not yet demonstrated in large trials
  • Many trials focused on safety, not clinical outcomes

Not Yet Demonstrated

  • Lifespan extension in humans
  • Reversal of biological aging
  • Consistent clinical outcomes across large populations
"

Despite extensive preclinical evidence demonstrating the benefits of NAD+, clinical studies still lag behind. To date, a limited number of trials have been completed, and many of these focused on safety, tolerability, and the ability of NAD+ precursors to increase NAD+ bioavailability.

— Khatri, Abdellatif & Sedej, Geromedicine 2025

Not All NAD+ Is Equal

Delivery route is a major theme of Dr. Craig Koniver's Huberman Lab interview. The order below reflects his clinical opinion, not head-to-head trial or pharmacokinetic data. None is cited on this page.

🥇

IV Infusion: Koniver's Top Pick (Opinion)

Koniver's #1 pick, based on his clinical practice. No IV NAD+ trial is cited here, and clinical benefits of NAD+ boosting are not yet demonstrated in trials.

🥈

Injection (SubQ/IM)

Mentioned as an alternative for those who can't access IV infusions. No pharmacokinetic comparison with oral forms is cited on this page.

🥉

NMN (Oral): Best Oral Option

Best oral option per Koniver. NMN sits one step closer to NAD+ in the biosynthesis pathway than NR; no head-to-head trial comparing how well the two convert is cited on this page.

4️⃣

NR (Oral)

Raises blood NAD+ in human trials. Koniver says it may reduce inflammation but the data is sparse, and he rates it less effective than NMN. Two steps from NAD+.

5️⃣

NAD+ Direct (Oral)

Ranked last in Koniver's order. No pharmacokinetic data on oral NAD+ absorption is cited on this page.

"If I had to pick one thing for people, engaging in NAD would be it."

— Dr. Craig Koniver, Huberman Lab Podcast, Oct 2024

What Koniver & Huberman Actually Said

Dr. Craig Koniver is a functional medicine physician who uses IV NAD+ in his practice. This section summarizes his October 2024 appearance on Huberman Lab: clinician opinion, not trial evidence.

💉

IV NAD+: Clinical Reality

Koniver describes the change he sees in patients on IV NAD+ as "almost inexplicable." That is a clinician's anecdote; no IV NAD+ trial is cited on this page.

💊

The Oral Hierarchy

Koniver's clear preference: NMN over NR over direct NAD+ for oral supplementation. His reasoning: proximity to NAD+ in the biosynthesis pathway. That fewer enzymatic steps means better conversion is his reasoning, not a trial finding cited here.

🎯

Who Might Benefit (Opinion)

Koniver's view is that people with lower baseline NAD+ (older, sick, or metabolically compromised) have the most room to gain, and healthy, fit individuals may have little room for improvement. That is clinician opinion. No trial on this page shows who benefits, and clinical benefits of NAD+ boosting are not yet demonstrated.

⏱️

Hair & Nails (Anecdote)

Koniver says patients on NMN report faster hair and nail growth. That is a clinician's anecdote, not a validated biomarker. No study of it is cited on this page.

NAD+ Precursors in Food

The main dietary NAD+ precursors are nicotinamide and nicotinic acid (niacin), often added to fortified staples like rice, flour, cereals, bread, pasta and milk (Khatri et al. 2025). The foods below are commonly listed niacin sources; this page cites no per-food content data.

🍗 Chicken / Turkey breast: niacin source
🐟 Tuna / Salmon: niacin source
🍄 Mushrooms: niacin source
🫛 Green peas: niacin source
🥑 Avocado: contains B3

Safety: What the Trials Show

In completed human trials of oral NR and NMN, no serious adverse effects have been reported. Niacin and IV NAD+ have their own considerations, below.

Oral NR / NMN: Well Tolerated The 2025 review (Khatri et al.) finds oral NAD+ precursors generally safe and well tolerated, with no indications of serious side effects. A minority of trials reported mild side effects, e.g. minor gastrointestinal symptoms, nausea, and diarrhea with NR combined with pterostilbene. Large, long-term NR/NMN trials remain scarce.

IV NAD+: No Trial Safety Data Cited No IV NAD+ safety data is cited on this page. The trial safety findings here cover oral NR/NMN only, not IV NAD+.

Niacin: Flushing is Common Skin flushing (redness, warmth, itching) is well-documented at higher doses.

Oral NR / NMN: No Serious Adverse Effects Reported The 2025 review (Khatri et al.) reports no serious adverse events in completed human trials of oral NR and NMN, supporting short-term tolerability for those two precursors. It is not a safety finding for niacin or IV NAD+.

Key Takeaways

Where does the science actually land? Here's the honest split between what's established and what's still speculation.

What We Know

  • Oral precursors (NR, NMN) raise blood NAD+ levels, with no serious adverse events reported in short-term trials
  • Oral NR/NMN showed no serious adverse effects in completed human trials
  • NAD+ is central to energy, DNA repair, and cellular signaling

What We Don't Know Yet

  • Whether raising NAD+ in healthy people produces meaningful clinical benefits
  • Long-term effects of chronic supplementation
  • The optimal precursor, dose, and delivery route
  • Whether supplements actually extend healthspan in humans
  • How large the age-related NAD+ decline is (this page cites no dataset for a specific figure)
  • Whether IV NAD+ helps: the support is clinician anecdote (Koniver), not trials
  • Whether animal findings will translate to humans

Sources

  • Khatri S, Abdellatif M, Sedej S. "Clinical evidence for the use of NAD+ precursors to slow aging." Geromedicine. 2025. — Primary review referenced throughout this guide.
  • PMC12022230 — NMN and NR skeletal muscle systematic review and meta-analysis (J Cachexia Sarcopenia Muscle). 2025. Pooled NMN trials showed no significant effect on muscle mass, grip strength, or gait speed; the authors concluded current evidence does not support NMN or NR for preserving muscle mass and function in adults with a mean age over 60.
  • Rice J, Lautrup S, Fang EF. "NAD(+) Boosting Strategies." Subcell Biochem. 2024 (PMID: 39693020). — Source for NAD+'s 1906 discovery by Harden and Young.
  • Bitterman KJ et al. "Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1." J Biol Chem. 2002 (PMID: 12297502).
  • FDA GRAS Notice GRN 635 — Nicotinamide riboside chloride (ChromaDex); closed Aug 3, 2016, FDA letter: no questions.
  • Huberman Lab Podcast — Dr. Craig Koniver episode, October 2024. Clinical practice perspective on IV NAD+, precursor hierarchy, and practical implementation.
  • StatPearls — NAD+ metabolism reference. Comprehensive biochemistry background on biosynthesis pathways, enzyme kinetics, and sirtuin activation.

NAD+ Precursor Supplements

NAD+ precursors discussed in this guide

🧬 NMN Supplement Oral NAD+ precursor ⚡ Tru Niagen / NR Nicotinamide riboside 💊 Niacin (B3) Budget-friendly precursor 🍇 Resveratrol Commonly stacked together

Affiliate links support HighPeptides at no extra cost.

📚

Want the Complete Protocol Guide?

Dosing schedules, interaction warnings, and cycle protocols for 20+ compounds, all in one place.


Get the Guide: $19 (normally $29) →
The Peptide Buyer’s Playbook ($19)

Educational content only. Not medical advice. This page is for informational purposes. NAD+ precursors (NMN, NR) are sold as dietary supplements, not FDA-approved treatments. IV NAD+ is administered in clinical settings. The research reviewed here includes preliminary and observational studies — do not interpret as established treatment guidelines. Always consult with a qualified healthcare provider before starting any supplementation protocol.

📘

Get the Free 2026 Peptide Protocol Stack

Twelve compounds across four pillars: metabolic, tissue repair, longevity, cognitive. Citations included, formatted to print. Sent straight to your inbox.